AIMS: To examine the implications for epidemiological studies of the American Diabetes Association (ADA) recommendation that the fasting blood glucose at a lowered level becomes the main diagnostic test for diabetes on cross-sectional-based data from sub-Saharan Africa. METHODS: Data from 11 surveys conducted in rural, peri-urban and urban Cameroon (n = 1804), South Africa (n = 3799) and Tanzania (n = 10013) which measured fasting (ADA criteria) and 2-h blood glucose concentrations during a standard 75 g OGTT (old WHO criteria) were analysed. RESULTS: The prevalence of diabetes was higher in eight of the 11 surveys when applying the new ADA compared to the old WHO criteria. With the exception of one population (Mara, Tanzania) the absolute difference in prevalence between the two classifications tended to be small (< 2%). There was considerable variation in the categorization of individuals using the ADA and old WHO criteria. The level of agreement between the two ranged from fair to good (Kappa statistic 0.17-0.86). The prevalence of impaired fasting glycaemia (IFG) was lower than that of impaired glucose tolerance (IGT) in 10 of the surveys and the agreement between the two was fair, < or = 0.26 in all the surveys. CONCLUSIONS: Although the use of the new ADA fasting criteria for prevalence surveys is an attractive and practical option, particularly in Africa, further information is required on the characteristics and prognosis of individuals classified as IFG or diabetic by the fasting criteria, prior to wide adoption of the ADA criteria. Ideally measurement of both fasting and two low glucose concentrations should remain the standard for epidemiological studies.
AIMS: To examine the implications for epidemiological studies of the American Diabetes Association (ADA) recommendation that the fasting blood glucose at a lowered level becomes the main diagnostic test for diabetes on cross-sectional-based data from sub-Saharan Africa. METHODS: Data from 11 surveys conducted in rural, peri-urban and urban Cameroon (n = 1804), South Africa (n = 3799) and Tanzania (n = 10013) which measured fasting (ADA criteria) and 2-h blood glucose concentrations during a standard 75 g OGTT (old WHO criteria) were analysed. RESULTS: The prevalence of diabetes was higher in eight of the 11 surveys when applying the new ADA compared to the old WHO criteria. With the exception of one population (Mara, Tanzania) the absolute difference in prevalence between the two classifications tended to be small (< 2%). There was considerable variation in the categorization of individuals using the ADA and old WHO criteria. The level of agreement between the two ranged from fair to good (Kappa statistic 0.17-0.86). The prevalence of impaired fasting glycaemia (IFG) was lower than that of impaired glucose tolerance (IGT) in 10 of the surveys and the agreement between the two was fair, < or = 0.26 in all the surveys. CONCLUSIONS: Although the use of the new ADA fasting criteria for prevalence surveys is an attractive and practical option, particularly in Africa, further information is required on the characteristics and prognosis of individuals classified as IFG or diabetic by the fasting criteria, prior to wide adoption of the ADA criteria. Ideally measurement of both fasting and two low glucose concentrations should remain the standard for epidemiological studies.
Authors: Stephanie T Chung; Amber B Courville; Anthony U Onuzuruike; Mirella Galvan-De La Cruz; Lilian S Mabundo; Christopher W DuBose; Kannan Kasturi; Hongyi Cai; Ahmed M Gharib; Peter J Walter; H Martin Garraffo; Shaji Chacko; Morey W Haymond; Anne E Sumner Journal: JCI Insight Date: 2018-09-20
Authors: Charles Agyemang; Karlijn Meeks; Erik Beune; Ellis Owusu-Dabo; Frank P Mockenhaupt; Juliet Addo; Ama de Graft Aikins; Silver Bahendeka; Ina Danquah; Matthias B Schulze; Joachim Spranger; Tom Burr; Peter Agyei-Baffour; Stephen K Amoah; Cecilia Galbete; Peter Henneman; Kerstin Klipstein-Grobusch; Mary Nicolaou; Adebowale Adeyemo; Jan van Straalen; Liam Smeeth; Karien Stronks Journal: BMC Med Date: 2016-10-21 Impact factor: 8.775
Authors: Davies Adeloye; Kit Yee Chan; Natasha Thorley; Charlotte Jones; David Johnstone; Ari L'Heveder; Vanja Saftic; David Henderson; Mickey Chopra; Harry Campbell; Igor Rudan Journal: J Glob Health Date: 2018-12 Impact factor: 4.413
Authors: Ram Jagannathan; Christopher W DuBose; Lilian S Mabundo; Stephanie T Chung; Joon Ha; Arthur Sherman; Michael Bergman; Anne E Sumner Journal: Diabetes Res Clin Pract Date: 2020-10-22 Impact factor: 5.602
Authors: Kim A Nguyen; Nasheeta Peer; Anniza de Villiers; Barbara Mukasa; Tandi E Matsha; Edward J Mills; Andre P Kengne Journal: PLoS One Date: 2019-01-31 Impact factor: 3.240